Company Data
Adagene Inc.
Ticker
ADAG
Current Price
$1.76 -2.76%
Market Cap
$77.6M
Price Target
Refer to Report
Volume
68.0K
52wk Range
$1.64 - $3.66
Overview
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company’s platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company’s immunotherapy pipeline.